Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125259233 | 12525923 | 3 | F | 20160622 | 20160718 | 20160705 | 20160726 | EXP | US-JNJFOC-20160622967 | JOHNSON AND JOHNSON | 38.00 | YR | A | F | Y | 167.50000 | KG | 20160726 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125259233 | 12525923 | 1 | PS | APAP/DOXYLAMINE/DEXTROMETHORPHAN | ACETAMINOPHENDEXTROMETHORPHAN HYDROBROMIDEDOXYLAMINE SUCCINATE | 1 | Oral | U | U | 0 | UNSPECIFIED | ||||||||
125259233 | 12525923 | 2 | SS | MORPHINE | MORPHINE | 1 | Oral | U | 0 | UNSPECIFIED | |||||||||
125259233 | 12525923 | 3 | SS | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Oral | U | 0 | UNSPECIFIED | |||||||||
125259233 | 12525923 | 4 | SS | ALL OTHER THERAPEUTIC PRODUCTS | UNSPECIFIED INGREDIENT | 1 | Oral | U | 0 | UNSPECIFIED | |||||||||
125259233 | 12525923 | 5 | C | MINOCYCLINE | MINOCYCLINEMINOCYCLINE HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
125259233 | 12525923 | 6 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
125259233 | 12525923 | 7 | C | DICLOFENAC | DICLOFENAC | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
125259233 | 12525923 | 8 | C | NAPROXEN. | NAPROXEN | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
125259233 | 12525923 | 9 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
125259233 | 12525923 | 10 | C | MS CONTIN | MORPHINE SULFATE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
125259233 | 12525923 | 11 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125259233 | 12525923 | 1 | Product used for unknown indication |
125259233 | 12525923 | 2 | Product used for unknown indication |
125259233 | 12525923 | 3 | Product used for unknown indication |
125259233 | 12525923 | 4 | Product used for unknown indication |
125259233 | 12525923 | 5 | Product used for unknown indication |
125259233 | 12525923 | 6 | Product used for unknown indication |
125259233 | 12525923 | 7 | Product used for unknown indication |
125259233 | 12525923 | 8 | Product used for unknown indication |
125259233 | 12525923 | 9 | Product used for unknown indication |
125259233 | 12525923 | 10 | Product used for unknown indication |
125259233 | 12525923 | 11 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125259233 | 12525923 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125259233 | 12525923 | Coma | |
125259233 | 12525923 | Extra dose administered | |
125259233 | 12525923 | Hypoxia | |
125259233 | 12525923 | Liver injury | |
125259233 | 12525923 | Respiratory depression | |
125259233 | 12525923 | Rhabdomyolysis | |
125259233 | 12525923 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |